Skip to main content
Top
Published in: Inflammation 5/2017

01-10-2017 | ORIGINAL ARTICLE

Protective Effects of Neural Crest-Derived Stem Cell-Conditioned Media against Ischemia-Reperfusion-Induced Lung Injury in Rats

Authors: Chung-Kan Peng, Shu-Yu Wu, Shih-En Tang, Min-Hui Li, Shih-Shiuan Lin, Shi-Jye Chu, Kun-Lun Huang

Published in: Inflammation | Issue 5/2017

Login to get access

Abstract

Current treatments for ischemia-reperfusion (IR)-induced acute lung injury are limited. Mesenchymal stem cell-conditioned medium (CM) has been reported to attenuate lung injury. Neural crest stem cells (NCSCs), a type of multipotent stem cells, are more easily obtained than mesenchymal stem cells. We hypothesize that NCSC-CM has anti-inflammatory properties that could protect against IR-induced lung injury in rats. In this study, NCSC-CM was derived from rat NCSCs. Typical acute lung injury was induced by 30-min ischemia followed by 90-min reperfusion in adult male Sprague–Dawley rats. Bronchoalveolar lavage fluid (BALF) and lung tissues were collected to analyze the degree of lung injury after the experiment. NCSC-CM was administered before ischemia and after reperfusion. NCSC-CM treatment significantly attenuated IR-induced lung edema, as indicated by decreases in pulmonary vascular permeability, lung weight gain, wet to dry weight ratio, lung weight to body weight ratio, pulmonary arterial pressure, and protein level in BALF. The levels of tumor necrosis factor-α and interleukin-6 in the BALF were also significantly decreased. Additionally, NCSC-CM improved lung pathology and neutrophil infiltration in the lung tissue, and significantly suppressed nuclear factor (NF)-κB activity and IκB-α degradation in the lung. However, heating NCSC-CM eliminated these protective effects. Our experiment demonstrates that NCSC-CM treatment decreases IR-induced acute lung injury and that the protective mechanism may be attributable to the inhibition of NF-κB activation and the inflammatory response. Therefore, NCSC-CM may be a novel approach for treating IR-induced lung injury.
Literature
1.
go back to reference Matthay, M.A., and G.A. Zimmerman. 2005. Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management. American Journal of Respiratory Cell and Molecular Biology 33: 319–327.CrossRefPubMedPubMedCentral Matthay, M.A., and G.A. Zimmerman. 2005. Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management. American Journal of Respiratory Cell and Molecular Biology 33: 319–327.CrossRefPubMedPubMedCentral
2.
go back to reference Monsel, A., Y.G. Zhu, S. Gennai, Q. Hao, J. Liu, and J.W. Lee. 2014. Cell-based therapy for acute organ injury: preclinical evidence and ongoing clinical trials using mesenchymal stem cells. Anesthesiology 121: 1099–1121.CrossRefPubMedPubMedCentral Monsel, A., Y.G. Zhu, S. Gennai, Q. Hao, J. Liu, and J.W. Lee. 2014. Cell-based therapy for acute organ injury: preclinical evidence and ongoing clinical trials using mesenchymal stem cells. Anesthesiology 121: 1099–1121.CrossRefPubMedPubMedCentral
3.
go back to reference Wang, Y.Y., X.Z. Li, and L.B. Wang. 2013. Therapeutic implications of mesenchymal stem cells in acute lung injury/acute respiratory distress syndrome. Stem Cell Research & Therapy 4: 45.CrossRef Wang, Y.Y., X.Z. Li, and L.B. Wang. 2013. Therapeutic implications of mesenchymal stem cells in acute lung injury/acute respiratory distress syndrome. Stem Cell Research & Therapy 4: 45.CrossRef
4.
go back to reference Curley, G.F., B. Ansari, M. Hayes, J. Devaney, C. Masterson, A. Ryan, F. Barry, T. O'Brien, D.O. Toole, and J.G. Laffey. 2013. Effects of intratracheal mesenchymal stromal cell therapy during recovery and resolution after ventilator-induced lung injury. Anesthesiology 118: 924–932.CrossRefPubMed Curley, G.F., B. Ansari, M. Hayes, J. Devaney, C. Masterson, A. Ryan, F. Barry, T. O'Brien, D.O. Toole, and J.G. Laffey. 2013. Effects of intratracheal mesenchymal stromal cell therapy during recovery and resolution after ventilator-induced lung injury. Anesthesiology 118: 924–932.CrossRefPubMed
5.
go back to reference Aslam, M., R. Baveja, O.D. Liang, A. Fernandez-Gonzalez, C. Lee, S.A. Mitsialis, and S. Kourembanas. 2009. Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease. American Journal of Respiratory and Critical Care Medicine 180: 1122–1130.CrossRefPubMedPubMedCentral Aslam, M., R. Baveja, O.D. Liang, A. Fernandez-Gonzalez, C. Lee, S.A. Mitsialis, and S. Kourembanas. 2009. Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease. American Journal of Respiratory and Critical Care Medicine 180: 1122–1130.CrossRefPubMedPubMedCentral
6.
go back to reference Makridakis, M., M.G. Roubelakis, and A. Vlahou. 2013. Stem cells: insights into the secretome. Biochimica et Biophysica Acta 1834: 2380–2384.CrossRefPubMed Makridakis, M., M.G. Roubelakis, and A. Vlahou. 2013. Stem cells: insights into the secretome. Biochimica et Biophysica Acta 1834: 2380–2384.CrossRefPubMed
7.
go back to reference Sieber-Blum, M. 2014. Human epidermal neural crest stem cells as candidates for cell-based therapies, disease modeling, and drug discovery. Birth Defects Research. Part C, Embryo Today 102: 221–226.CrossRefPubMed Sieber-Blum, M. 2014. Human epidermal neural crest stem cells as candidates for cell-based therapies, disease modeling, and drug discovery. Birth Defects Research. Part C, Embryo Today 102: 221–226.CrossRefPubMed
8.
go back to reference Sieber-Blum, M., M. Grim, Y.F. Hu, and V. Szeder. 2004. Pluripotent neural crest stem cells in the adult hair follicle. Developmental Dynamics 231: 258–269.CrossRefPubMed Sieber-Blum, M., M. Grim, Y.F. Hu, and V. Szeder. 2004. Pluripotent neural crest stem cells in the adult hair follicle. Developmental Dynamics 231: 258–269.CrossRefPubMed
9.
go back to reference Ionescu, L., R.N. Byrne, T. van Haaften, A. Vadivel, R.S. Alphonse, G.J. Rey-Parra, G. Weissmann, A. Hall, F. Eaton, and B. Thebaud. 2012. Stem cell conditioned medium improves acute lung injury in mice: in vivo evidence for stem cell paracrine action. American Journal of Physiology. Lung Cellular and Molecular Physiology 303: L967–L977.CrossRefPubMedPubMedCentral Ionescu, L., R.N. Byrne, T. van Haaften, A. Vadivel, R.S. Alphonse, G.J. Rey-Parra, G. Weissmann, A. Hall, F. Eaton, and B. Thebaud. 2012. Stem cell conditioned medium improves acute lung injury in mice: in vivo evidence for stem cell paracrine action. American Journal of Physiology. Lung Cellular and Molecular Physiology 303: L967–L977.CrossRefPubMedPubMedCentral
10.
go back to reference Peng, C.K., K.L. Huang, C.P. Wu, M.H. Li, Y.T. Hu, C.W. Hsu, S.H. Tsai, and S.J. Chu. 2011. Glutamine protects ischemia-reperfusion induced acute lung injury in isolated rat lungs. Pulmonary Pharmacology & Therapeutics 24: 153–161.CrossRef Peng, C.K., K.L. Huang, C.P. Wu, M.H. Li, Y.T. Hu, C.W. Hsu, S.H. Tsai, and S.J. Chu. 2011. Glutamine protects ischemia-reperfusion induced acute lung injury in isolated rat lungs. Pulmonary Pharmacology & Therapeutics 24: 153–161.CrossRef
11.
go back to reference Wu, S.Y., S.E. Tang, F.C. Ko, G.C. Wu, K.L. Huang, and S.J. Chu. 2015. Valproic acid attenuates acute lung injury induced by ischemia-reperfusion in rats. Anesthesiology 122: 1327–1337.CrossRefPubMed Wu, S.Y., S.E. Tang, F.C. Ko, G.C. Wu, K.L. Huang, and S.J. Chu. 2015. Valproic acid attenuates acute lung injury induced by ischemia-reperfusion in rats. Anesthesiology 122: 1327–1337.CrossRefPubMed
12.
go back to reference Wu, S.Y., M.H. Li, F.C. Ko, G.C. Wu, K.L. Huang, and S.J. Chu. 2013. Protective effect of hypercapnic acidosis in ischemia-reperfusion lung injury is attributable to upregulation of heme oxygenase-1. PloS One 8: e74742.CrossRefPubMedPubMedCentral Wu, S.Y., M.H. Li, F.C. Ko, G.C. Wu, K.L. Huang, and S.J. Chu. 2013. Protective effect of hypercapnic acidosis in ischemia-reperfusion lung injury is attributable to upregulation of heme oxygenase-1. PloS One 8: e74742.CrossRefPubMedPubMedCentral
13.
go back to reference Wu, S.Y., C.P. Wu, B.H. Kang, M.H. Li, S.J. Chu, and K.L. Huang. 2012. Hypercapnic acidosis attenuates reperfusion injury in isolated and perfused rat lungs. Critical Care Medicine 40: 553–559.CrossRefPubMed Wu, S.Y., C.P. Wu, B.H. Kang, M.H. Li, S.J. Chu, and K.L. Huang. 2012. Hypercapnic acidosis attenuates reperfusion injury in isolated and perfused rat lungs. Critical Care Medicine 40: 553–559.CrossRefPubMed
14.
go back to reference Parekkadan, B., D. van Poll, K. Suganuma, E.A. Carter, F. Berthiaume, A.W. Tilles, and M.L. Yarmush. 2007. Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. PloS One 2: e941.CrossRefPubMedPubMedCentral Parekkadan, B., D. van Poll, K. Suganuma, E.A. Carter, F. Berthiaume, A.W. Tilles, and M.L. Yarmush. 2007. Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. PloS One 2: e941.CrossRefPubMedPubMedCentral
15.
go back to reference Cantinieaux, D., R. Quertainmont, S. Blacher, L. Rossi, T. Wanet, A. Noel, G. Brook, J. Schoenen, and R. Franzen. 2013. Conditioned medium from bone marrow-derived mesenchymal stem cells improves recovery after spinal cord injury in rats: an original strategy to avoid cell transplantation. PloS One 8: e69515.CrossRefPubMedPubMedCentral Cantinieaux, D., R. Quertainmont, S. Blacher, L. Rossi, T. Wanet, A. Noel, G. Brook, J. Schoenen, and R. Franzen. 2013. Conditioned medium from bone marrow-derived mesenchymal stem cells improves recovery after spinal cord injury in rats: an original strategy to avoid cell transplantation. PloS One 8: e69515.CrossRefPubMedPubMedCentral
16.
go back to reference Gnecchi, M., H. He, N. Noiseux, O.D. Liang, L. Zhang, F. Morello, H. Mu, L.G. Melo, R.E. Pratt, J.S. Ingwall, and V.J. Dzau. 2006. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. The FASEB Journal 20: 661–669.CrossRefPubMed Gnecchi, M., H. He, N. Noiseux, O.D. Liang, L. Zhang, F. Morello, H. Mu, L.G. Melo, R.E. Pratt, J.S. Ingwall, and V.J. Dzau. 2006. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. The FASEB Journal 20: 661–669.CrossRefPubMed
17.
go back to reference Walter, M.N., K.T. Wright, H.R. Fuller, S. MacNeil, and W.E. Johnson. 2010. Mesenchymal stem cell-conditioned medium accelerates skin wound healing: an in vitro study of fibroblast and keratinocyte scratch assays. Experimental Cell Research 316: 1271–1281.CrossRefPubMed Walter, M.N., K.T. Wright, H.R. Fuller, S. MacNeil, and W.E. Johnson. 2010. Mesenchymal stem cell-conditioned medium accelerates skin wound healing: an in vitro study of fibroblast and keratinocyte scratch assays. Experimental Cell Research 316: 1271–1281.CrossRefPubMed
18.
go back to reference Lee, J.W., X. Fang, N. Gupta, V. Serikov, and M.A. Matthay. 2009. Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proceedings of the National Academy of Sciences of the United States of America 106: 16357–16362.CrossRefPubMedPubMedCentral Lee, J.W., X. Fang, N. Gupta, V. Serikov, and M.A. Matthay. 2009. Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proceedings of the National Academy of Sciences of the United States of America 106: 16357–16362.CrossRefPubMedPubMedCentral
19.
go back to reference Sun, C.K., C.H. Yen, Y.C. Lin, T.H. Tsai, L.T. Chang, Y.H. Kao, S. Chua, M. Fu, S.F. Ko, S. Leu, and H.K. Yip. 2011. Autologous transplantation of adipose-derived mesenchymal stem cells markedly reduced acute ischemia-reperfusion lung injury in a rodent model. Journal of Translational Medicine 9: 118.CrossRefPubMedPubMedCentral Sun, C.K., C.H. Yen, Y.C. Lin, T.H. Tsai, L.T. Chang, Y.H. Kao, S. Chua, M. Fu, S.F. Ko, S. Leu, and H.K. Yip. 2011. Autologous transplantation of adipose-derived mesenchymal stem cells markedly reduced acute ischemia-reperfusion lung injury in a rodent model. Journal of Translational Medicine 9: 118.CrossRefPubMedPubMedCentral
20.
go back to reference Chen, S., L. Chen, X. Wu, J. Lin, J. Fang, X. Chen, S. Wei, J. Xu, Q. Gao, and M. Kang. 2012. Ischemia postconditioning and mesenchymal stem cells engraftment synergistically attenuate ischemia reperfusion-induced lung injury in rats. The Journal of Surgical Research 178: 81–91.CrossRefPubMed Chen, S., L. Chen, X. Wu, J. Lin, J. Fang, X. Chen, S. Wei, J. Xu, Q. Gao, and M. Kang. 2012. Ischemia postconditioning and mesenchymal stem cells engraftment synergistically attenuate ischemia reperfusion-induced lung injury in rats. The Journal of Surgical Research 178: 81–91.CrossRefPubMed
21.
go back to reference Manning, E., S. Pham, S. Li, R.I. Vazquez-Padron, J. Mathew, P. Ruiz, and S.K. Salgar. 2010. Interleukin-10 delivery via mesenchymal stem cells: a novel gene therapy approach to prevent lung ischemia-reperfusion injury. Human Gene Therapy 21: 713–727.CrossRefPubMed Manning, E., S. Pham, S. Li, R.I. Vazquez-Padron, J. Mathew, P. Ruiz, and S.K. Salgar. 2010. Interleukin-10 delivery via mesenchymal stem cells: a novel gene therapy approach to prevent lung ischemia-reperfusion injury. Human Gene Therapy 21: 713–727.CrossRefPubMed
23.
go back to reference McCarter, S.D., S.H. Mei, P.F. Lai, Q.W. Zhang, C.H. Parker, R.S. Suen, R.D. Hood, Y.D. Zhao, Y. Deng, R.N. Han, D.J. Dumont, and D.J. Stewart. 2007. Cell-based angiopoietin-1 gene therapy for acute lung injury. American Journal of Respiratory and Critical Care Medicine 175: 1014–1026.CrossRefPubMed McCarter, S.D., S.H. Mei, P.F. Lai, Q.W. Zhang, C.H. Parker, R.S. Suen, R.D. Hood, Y.D. Zhao, Y. Deng, R.N. Han, D.J. Dumont, and D.J. Stewart. 2007. Cell-based angiopoietin-1 gene therapy for acute lung injury. American Journal of Respiratory and Critical Care Medicine 175: 1014–1026.CrossRefPubMed
24.
go back to reference Lee, J.W., X. Fang, A. Krasnodembskaya, J.P. Howard, and M.A. Matthay. 2011. Concise review: mesenchymal stem cells for acute lung injury: role of paracrine soluble factors. Stem Cells 29: 913–919.CrossRefPubMedPubMedCentral Lee, J.W., X. Fang, A. Krasnodembskaya, J.P. Howard, and M.A. Matthay. 2011. Concise review: mesenchymal stem cells for acute lung injury: role of paracrine soluble factors. Stem Cells 29: 913–919.CrossRefPubMedPubMedCentral
25.
go back to reference Hunter, C.A., and S.A. Jones. 2015. IL-6 as a keystone cytokine in health and disease. Nature Immunology 16: 448–457.CrossRefPubMed Hunter, C.A., and S.A. Jones. 2015. IL-6 as a keystone cytokine in health and disease. Nature Immunology 16: 448–457.CrossRefPubMed
26.
go back to reference Lauder, S.N., E. Jones, K. Smart, A. Bloom, A.S. Williams, J.P. Hindley, B. Ondondo, P.R. Taylor, M. Clement, C. Fielding, A.J. Godkin, S.A. Jones, and A.M. Gallimore. 2013. Interleukin-6 limits influenza-induced inflammation and protects against fatal lung pathology. European Journal of Immunology 43: 2613–2625.CrossRefPubMed Lauder, S.N., E. Jones, K. Smart, A. Bloom, A.S. Williams, J.P. Hindley, B. Ondondo, P.R. Taylor, M. Clement, C. Fielding, A.J. Godkin, S.A. Jones, and A.M. Gallimore. 2013. Interleukin-6 limits influenza-induced inflammation and protects against fatal lung pathology. European Journal of Immunology 43: 2613–2625.CrossRefPubMed
27.
go back to reference Ward, N.S., A.B. Waxman, R.J. Homer, L.L. Mantell, O. Einarsson, Y. Du, and J.A. Elias. 2000. Interleukin-6-induced protection in hyperoxic acute lung injury. American Journal of Respiratory Cell and Molecular Biology 22: 535–542.CrossRefPubMed Ward, N.S., A.B. Waxman, R.J. Homer, L.L. Mantell, O. Einarsson, Y. Du, and J.A. Elias. 2000. Interleukin-6-induced protection in hyperoxic acute lung injury. American Journal of Respiratory Cell and Molecular Biology 22: 535–542.CrossRefPubMed
28.
go back to reference Zhang, S., S.D. Danchuk, R.W. Bonvillain, B. Xu, B.A. Scruggs, A.L. Strong, J.A. Semon, J.M. Gimble, A.M. Betancourt, D.E. Sullivan, and B.A. Bunnell. 2014. Interleukin 6 mediates the therapeutic effects of adipose-derived stromal/stem cells in lipopolysaccharide-induced acute lung injury. Stem Cells 32: 1616–1628.CrossRefPubMedPubMedCentral Zhang, S., S.D. Danchuk, R.W. Bonvillain, B. Xu, B.A. Scruggs, A.L. Strong, J.A. Semon, J.M. Gimble, A.M. Betancourt, D.E. Sullivan, and B.A. Bunnell. 2014. Interleukin 6 mediates the therapeutic effects of adipose-derived stromal/stem cells in lipopolysaccharide-induced acute lung injury. Stem Cells 32: 1616–1628.CrossRefPubMedPubMedCentral
30.
go back to reference Yamaguchi, S., R. Shibata, N. Yamamoto, M. Nishikawa, H. Hibi, T. Tanigawa, M. Ueda, T. Murohara, and A. Yamamoto. 2015. Dental pulp-derived stem cell conditioned medium reduces cardiac injury following ischemia-reperfusion. Scientific Reports 5: 16295.CrossRefPubMedPubMedCentral Yamaguchi, S., R. Shibata, N. Yamamoto, M. Nishikawa, H. Hibi, T. Tanigawa, M. Ueda, T. Murohara, and A. Yamamoto. 2015. Dental pulp-derived stem cell conditioned medium reduces cardiac injury following ischemia-reperfusion. Scientific Reports 5: 16295.CrossRefPubMedPubMedCentral
31.
go back to reference Lee, S.C., J.O. Kim, and S.J. Kim. 2015. Secretome from human adipose-derived stem cells protects mouse liver from hepatic ischemia-reperfusion injury. Surgery 157: 934–943.CrossRefPubMed Lee, S.C., J.O. Kim, and S.J. Kim. 2015. Secretome from human adipose-derived stem cells protects mouse liver from hepatic ischemia-reperfusion injury. Surgery 157: 934–943.CrossRefPubMed
32.
go back to reference Carceller, M.C., M.I. Guillen, M.L. Ferrandiz, and M.J. Alcaraz. 2015. Paracrine in vivo inhibitory effects of adipose tissue-derived mesenchymal stromal cells in the early stages of the acute inflammatory response. Cytotherapy 17: 1230–1239.CrossRefPubMed Carceller, M.C., M.I. Guillen, M.L. Ferrandiz, and M.J. Alcaraz. 2015. Paracrine in vivo inhibitory effects of adipose tissue-derived mesenchymal stromal cells in the early stages of the acute inflammatory response. Cytotherapy 17: 1230–1239.CrossRefPubMed
33.
go back to reference Liu, S.F., and A.B. Malik. 2006. NF-kappa B activation as a pathological mechanism of septic shock and inflammation. American Journal of Physiology. Lung Cellular and Molecular Physiology 290: L622–L645.CrossRefPubMed Liu, S.F., and A.B. Malik. 2006. NF-kappa B activation as a pathological mechanism of septic shock and inflammation. American Journal of Physiology. Lung Cellular and Molecular Physiology 290: L622–L645.CrossRefPubMed
34.
go back to reference Libermann, T.A., and D. Baltimore. 1990. Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Molecular and Cellular Biology 10: 2327–2334.CrossRefPubMedPubMedCentral Libermann, T.A., and D. Baltimore. 1990. Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Molecular and Cellular Biology 10: 2327–2334.CrossRefPubMedPubMedCentral
35.
go back to reference Yagi, H., A. Soto-Gutierrez, N. Navarro-Alvarez, Y. Nahmias, Y. Goldwasser, Y. Kitagawa, A.W. Tilles, R.G. Tompkins, B. Parekkadan, and M.L. Yarmush. 2010. Reactive bone marrow stromal cells attenuate systemic inflammation via sTNFR1. Molecular Therapy 18: 1857–1864.CrossRefPubMedPubMedCentral Yagi, H., A. Soto-Gutierrez, N. Navarro-Alvarez, Y. Nahmias, Y. Goldwasser, Y. Kitagawa, A.W. Tilles, R.G. Tompkins, B. Parekkadan, and M.L. Yarmush. 2010. Reactive bone marrow stromal cells attenuate systemic inflammation via sTNFR1. Molecular Therapy 18: 1857–1864.CrossRefPubMedPubMedCentral
36.
go back to reference Sun, C.K., S. Leu, S.Y. Hsu, Y.Y. Zhen, L.T. Chang, C.Y. Tsai, Y.L. Chen, Y.T. Chen, T.H. Tsai, F.Y. Lee, J.J. Sheu, H.W. Chang, and H.K. Yip. 2015. Mixed serum-deprived and normal adipose-derived mesenchymal stem cells against acute lung ischemia-reperfusion injury in rats. American Journal of Translational Research 7: 209–231.PubMedPubMedCentral Sun, C.K., S. Leu, S.Y. Hsu, Y.Y. Zhen, L.T. Chang, C.Y. Tsai, Y.L. Chen, Y.T. Chen, T.H. Tsai, F.Y. Lee, J.J. Sheu, H.W. Chang, and H.K. Yip. 2015. Mixed serum-deprived and normal adipose-derived mesenchymal stem cells against acute lung ischemia-reperfusion injury in rats. American Journal of Translational Research 7: 209–231.PubMedPubMedCentral
37.
go back to reference Gennai, S., A. Monsel, Q. Hao, J. Park, M.A. Matthay, and J.W. Lee. 2015. Microvesicles derived from human mesenchymal stem cells restore alveolar fluid clearance in human lungs rejected for transplantation. American Journal of Transplantation 15: 2404–2412.CrossRefPubMedPubMedCentral Gennai, S., A. Monsel, Q. Hao, J. Park, M.A. Matthay, and J.W. Lee. 2015. Microvesicles derived from human mesenchymal stem cells restore alveolar fluid clearance in human lungs rejected for transplantation. American Journal of Transplantation 15: 2404–2412.CrossRefPubMedPubMedCentral
38.
go back to reference Akyurekli, C., Y. Le, R.B. Richardson, D. Fergusson, J. Tay, and D.S. Allan. 2015. A systematic review of preclinical studies on the therapeutic potential of mesenchymal stromal cell-derived microvesicles. Stem Cell Reviews 11: 150–160.CrossRefPubMed Akyurekli, C., Y. Le, R.B. Richardson, D. Fergusson, J. Tay, and D.S. Allan. 2015. A systematic review of preclinical studies on the therapeutic potential of mesenchymal stromal cell-derived microvesicles. Stem Cell Reviews 11: 150–160.CrossRefPubMed
Metadata
Title
Protective Effects of Neural Crest-Derived Stem Cell-Conditioned Media against Ischemia-Reperfusion-Induced Lung Injury in Rats
Authors
Chung-Kan Peng
Shu-Yu Wu
Shih-En Tang
Min-Hui Li
Shih-Shiuan Lin
Shi-Jye Chu
Kun-Lun Huang
Publication date
01-10-2017
Publisher
Springer US
Published in
Inflammation / Issue 5/2017
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-017-0594-5

Other articles of this Issue 5/2017

Inflammation 5/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.